Most countries have reasonably protected budgets for scientific research, despite the recession, though it still makes sense for companies to look towards the Asian markets as a growth area. However, whilst the predicted move of genome sequencing into clinical application is an important development, health budgets in many countries may be more squeezed than research ones.

comments powered by Disqus

External links